These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20832210)

  • 1. L-arginine is effective in stroke-like episodes of MELAS associated with the G13513A mutation.
    Shigemi R; Fukuda M; Suzuki Y; Morimoto T; Ishii E
    Brain Dev; 2011 Jun; 33(6):518-20. PubMed ID: 20832210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MELAS and L-arginine therapy.
    Koga Y; Akita Y; Nishioka J; Yatsuga S; Povalko N; Katayama K; Matsuishi T
    Mitochondrion; 2007; 7(1-2):133-9. PubMed ID: 17276739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effect of L-arginine for stroke-like episode in MELAS.
    Kubota M; Sakakihara Y; Mori M; Yamagata T; Momoi-Yoshida M
    Brain Dev; 2004 Oct; 26(7):481-3; discussion 480. PubMed ID: 15351086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of long-term oral treatment with L-arginine and idebenone on the prevention of stroke-like episodes in an adult MELAS patient.
    Lekoubou A; Kouamé-Assouan AE; Cho TH; Luauté J; Nighoghossian N; Derex L
    Rev Neurol (Paris); 2011 Nov; 167(11):852-5. PubMed ID: 21514942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and radiologic reversal of stroke-like episodes in MELAS with high-dose L-arginine.
    Siddiq I; Widjaja E; Tein I
    Neurology; 2015 Jul; 85(2):197-8. PubMed ID: 26070336
    [No Abstract]   [Full Text] [Related]  

  • 6. [Determination of the critical time point for efficacy of L-arginine infusion therapy in a case of MELAS with frequent stroke-like episodes].
    Sudo A; Sano H; Kawamura N
    No To Hattatsu; 2014 Jan; 46(1):39-43. PubMed ID: 24620430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-arginine improves the symptoms of strokelike episodes in MELAS.
    Koga Y; Akita Y; Nishioka J; Yatsuga S; Povalko N; Tanabe Y; Fujimoto S; Matsuishi T
    Neurology; 2005 Feb; 64(4):710-2. PubMed ID: 15728297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MELAS and L-arginine therapy: pathophysiology of stroke-like episodes.
    Koga Y; Povalko N; Nishioka J; Katayama K; Kakimoto N; Matsuishi T
    Ann N Y Acad Sci; 2010 Jul; 1201():104-10. PubMed ID: 20649546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [l-arginine efficiency in MELAS syndrome. A case report].
    Moutaouakil F; El Otmani H; Fadel H; Sefrioui F; Slassi I
    Rev Neurol (Paris); 2009 May; 165(5):482-5. PubMed ID: 18849057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment options for mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome.
    Santa KM
    Pharmacotherapy; 2010 Nov; 30(11):1179-96. PubMed ID: 20973690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial dysfunction in MELAS improved by l-arginine supplementation.
    Koga Y; Akita Y; Junko N; Yatsuga S; Povalko N; Fukiyama R; Ishii M; Matsuishi T
    Neurology; 2006 Jun; 66(11):1766-9. PubMed ID: 16769961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel mutation in the mtDNA ND5 gene associated with MELAS.
    Santorelli FM; Tanji K; Kulikova R; Shanske S; Vilarinho L; Hays AP; DiMauro S
    Biochem Biophys Res Commun; 1997 Sep; 238(2):326-8. PubMed ID: 9299505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes: an important cause of stroke in young people.
    Goodfellow JA; Dani K; Stewart W; Santosh C; McLean J; Mulhern S; Razvi S
    Postgrad Med J; 2012 Jun; 88(1040):326-34. PubMed ID: 22328278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute hearing loss in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS).
    Chen JC; Tsai TC; Liu CS; Lu CT
    Acta Neurol Taiwan; 2007 Sep; 16(3):168-72. PubMed ID: 17966957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular pathology of MELAS and L-arginine effects.
    Koga Y; Povalko N; Nishioka J; Katayama K; Yatsuga S; Matsuishi T
    Biochim Biophys Acta; 2012 May; 1820(5):608-14. PubMed ID: 21944974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of L-arginine on the acute phase of strokes in three patients with MELAS.
    Koga Y; Ishibashi M; Ueki I; Yatsuga S; Fukiyama R; Akita Y; Matsuishi T
    Neurology; 2002 Mar; 58(5):827-8. PubMed ID: 11889254
    [No Abstract]   [Full Text] [Related]  

  • 17. MELAS: Monitoring treatment with magnetic resonance spectroscopy.
    Hovsepian DA; Galati A; Chong RA; Mazumder R; DeGiorgio CM; Mishra S; Yim C
    Acta Neurol Scand; 2019 Jan; 139(1):82-85. PubMed ID: 30216413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-Arginine prevents stroke-like episodes but not brain atrophy: a 20-year follow-up of a MELAS patient.
    Wei Y; Cui L; Pen B
    Neurol Sci; 2019 Jan; 40(1):209-211. PubMed ID: 30218398
    [No Abstract]   [Full Text] [Related]  

  • 19. Paralytic ileus in MELAS with phenotypic features of MNGIE.
    Chang TM; Chi CS; Tsai CR; Lee HF; Li MC
    Pediatr Neurol; 2004 Nov; 31(5):374-7. PubMed ID: 15519124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR evaluation of cerebral oxygen metabolism and blood flow in stroke-like episodes of MELAS.
    Wang Z; Xiao J; Xie S; Zhao D; Liu X; Zhang J; Yuan Y; Huang Y
    J Neurol Sci; 2012 Dec; 323(1-2):173-7. PubMed ID: 23062409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.